DIABETIC EFFECTS OF POLYHERBAL FORMULATION OF     LAWSONIA INERMIS AND AZADIRACHTA INDICA by Rajwar, Sonam & Khatri, Pankaj
Rajwar et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(2), 45-51   45 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
DIABETIC EFFECTS OF POLYHERBAL FORMULATION OF     LAWSONIA INERMIS 
AND AZADIRACHTA INDICA 
*
Sonam Rajwar, Pankaj Khatri 
Department of Pharmacognosy, Gyan Vihar School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur-
302025, Rajasthan, India. 
*Corresponding Author’s Email: sonamrajwar@gmail.com 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Lawsonia inermis, commonly called as Henna and the 
synonym is Lawsonia alba Linn. belongs to family 
Lythraceae1 . It is indigeneous to Africa and is largely 
cultivated in Egypt, Sudan, Carribean islands, Florida, 
India and China2. The principal colouring matter of henna 
is lawsone, 2-hydroxy-1:4 napthaquinone besides lawsone 
other constituents present are gallic acid, glucose, 
mannitol, fats, resin (2 %), mucilage and traces of an 
alkaloid. Leaves yield hennatannic acid and an olive oil 
green resin, soluble in ether and alcohol. Flowers yield an 
essential oil (0.01-0.02 %) consist mainly of α- and β- 
ionones; a nitrogenous compound and resin. Seeds contain 
proteins (5.0 %), carbohydrates (33.62 %), fibers (33.5 %), 
fatty oils (10-11 %) composed of behenic acid, arachidic 
acid, stearic acid, palmitic acid, oleic acid and linoleic 
acid3. Lawsonia inermis leaves (mehendi) are very popular 
natural dye to finger, color hand, nails and hair4. As a 
medicinal plant, henna has been used for astringent, anti 
hemorrhagic, intestinal antineoplastic, cardio-inhibitory, 
hypertensive and sedative effects and used as a folk 
remedy against amoebiasis, headache jaundice and 
leprosy5. 
Azadirachta indica A. Juss (syn. Melia azadirachta), is 
popularly known as Indian neem (margosa tree) or Indian 
lilac6. It is a versatile tree native to South and South-East 
Asia, Japan, tropical USA, South America, Australia and 
Africa7. Biologically active principles isolated from 
different parts of the plant include: azadiractin, meliacin, 
gedunin, salanin, nimbin, valassin and many other 
derivatives of these principles, Meliacin forms the bitter 
principles of neem seed oil; the seed also contain tignic 
acid (5-methyl-2-butanic acid) responsible for the 
distinctive odour of the oil. These compounds belong to 
natural products called triterpenoids (Limonoids). It 
possess maximum useful non-wood products such as 
leaves, bark, flowers fruits, seeds, gum, oil and neem cake 
than any other species. It is known to have antiallergenic, 
antidermatic, antifeedant, antiviral, antifungal, anti-
inflammatory, antipyorrhoeic, antiscabic insecticidal, 
larvicidal, anti-implantation, nermaticidal, spermatocidal 
and other biological activities8. 
Diabetes mellitus (DM) is a group of metabolic diseases 
characterized by hyperglycaemia, hypertriglyceridaemia 
and hypercholesterolaemia, resulting from defects in 
insulin secretion or action or both10. It is the world’s 
largest endocrine disease, according to the WHO 
projections, the prevalence of diabetes is likely to increase 
by 35%. Statistical projections about India suggest that the 
number of diabetics will rise from 15 million in 1995 to 57 
million in the year of 2025 making it the country with the 
highest number of diabetics in the world9.  
Symptoms of Diabetes mellitus are polyuria, polydipsia, 
losing weight without trying, blurry vision, Frequent 
infections- including skin infections, thrush, gingivitis, 
urinary tract infections and yeast infections, Slow healing 
of sores, Skin problems, such as itchiness or acanthosis 
Nigricans, Dizziness or fainting11. Two groups of oral 
hypoglycaemic drugs, sulphonylureas and biguanides, 
have been used in the treatment of Diabetes mellitus10. 
Common side effects of Synthetic drugs are - 
Hypoglycaemia, Nausea, Vomiting, Diarrhoea, 
Constipation, Headache, Anorexia12. While our herbal 
drugs are also stand for the treatment of Diabetes mellitus 
with less or no unwanted effects as compare to synthetic 
diabetic medicines. Some herbal antidiabetic drugs are 
Achillea ligutica, Aegles marmelos, Andrographis 
paniculata, Azadirachta indica etc.13 It is very important to 
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investigate the derived from natural products, which were 
used in traditional system of medicines for the treatment of 
diabetes mellitus so hypoglycemic agent have focused on 
plants which are used in traditional system of medicines 
because they may be better treatment than synthetic drugs 
which are available in market
18
. The present research 
article deals with the aim of evaluating the combined 
effects of Formulation of Lawsonia inermis and 
Azadirachta indica leaves extract on blood glucose level, 
body weight in alloxan diabetic and streptozocin diabetic 
rats. 
MATERIAL AND METHOD 
Plant materials: The Leaves of Lawsonia inermis and 
Azadirachta indica were collected from the local areas of 
Jaipur, Rajasthan during April and October 2011 
respectively and were authenticated by Mr. Vinod Kumar 
Sharma, Department of Botany, Rajasthan University 
Jaipur, Rajasthan. Voucher specimen were deposited in the 
departmental herbarium of Rajasthan University, Jaipur, 
India for future reference. 
Chemicals: Glibenclamide Tablet (5mg) was purchased 
from Aventis Pharma, Alloxan was purchased from 
Central drug house, Glimiperide Tablet (5mg) was 
purchased from Aventis Pharma, Streptozotocin was 
purchased from Sigma chemicals, Gum acacia was 
purchased from Central drug house, Normal saline was 
purchased from Central drug house, Glucose was 
purchased from Central drug house, Digital Display 
Glucometer was purchased from Johnson & Johnson. 
1 Polyherbal Formulation: 
1.1 Preparation of Extract of Lawsonia inermis by Hot 
Continuous Extraction Method
14, 15
: 
Fresh leaves of Lawsonia inermis was collected from the 
local area of Jaipur, were washed in tap water and then left 
to dry at room temperature for 2-3 days. The dried leaves 
were then ground to fine powder in a mixer. A Total of 
250gm of shade dried and powdered leaves of Lawsonia 
inermis was used for the analysis. Powdered plant material 
was subjected to extraction with petroleum ether in a 
soxhlet apparatus. The extraction was continued till the 
defatting of the plant material had completely done. The 
deffated marc was extracted successively with aqueous 
ethanol by soxhlet apparatus. The extraction was carried 
out until the drug becomes exhausted. The solvents were 
recovered from their extract by distillation under reduced 
pressure. The solvent was dried and concentrated using 
Rotary evaporator at 650C. The extract was than analysed 
by thin layer chromatography to isolate the 
phytoconstituents responsible for diabetic activity. The 
solvent system used was butanol: acetic acid: water (6: 2: 
1) and the extract was also further analysed by High 
Performance Liquid Chromatography. 
1.2 Preparation of Extract of Azadirachta indica by Hot 
Continuous Extraction Method
16, 17
: 
The Azadirachta indica leaves was collected from the local 
area of Jaipur, cleaned, dried and powdered in a grinder–
mixer to obtain a coarse powder and then passed through 
40 mesh sieve. A Total of 250gm of shade dried and 
powdered leaves of Azadirahcta indica was used for the 
analysis.Powdered plant material was subjected to 
extraction with petroleum ether in a soxhlet apparatus. The 
extraction was continued till the defatting of the plant 
material had completely done. The deffated marc of the 
drugs was subjected to extraction with 70% ethanol in a 
Soxhlet apparatus. The extraction was carried out until the 
drug becomes exhausted. The Ethanolic extract was 
concentrate at 650C by a rotavapor16,17.The extract was 
than analysed by thin layer chromatography to isolate the 
phytoconstituents responsible for diabetic activity. The 
solvent system used was Hexane: ethylacetate (3:7), 
Chloroform: methanol (97:3), Benzene: acetic acid: water 
(125: 72: 3) and the extract was also further analysed by 
High Performance Liquid Chromatography. 
1.3 Polyherbal formulations of Lawsonia inermis and 
Azadirachta indica extract:-  
The extracts obtained after concentrating by a rotavapor at 
650C were dried to obtain a powder. Now the polyherbal 
formulation of Lawsonia inermis and Azadirachta indica 
with various concentrate gradients were developed as 
shown in Table no-1 which was than further analysed for 
Phytochemical and Pharmacological studies.
 
Table 1: Effect of F1 , F2, F3, F4 & F5 on alloxan induced diabetic rats 
[** Extremely sigmificant (P<0.01), * Significant (p< 0.05), ns- Not significant (P> 0.05)] 
Treatment and Dose 
(mg/kg p. o) 
Serum glucose level (mg/dl) 
0 day 2 nd day 5th day 10th day 
Control Group 266.48 ± 3.73 269.16 ± 3.15 265.33 ± 3.76 268.29 ± 2.41 
Reference Group
* 
(Glibenclamide)
 
263.06 ± 3.58 224.00 ± 2.91 210.76 ± 4.59 182.66 ± 1.72 
F1 * 289.83 ± 2.34 250.41 ± 3.22 233.18 ± 2.63 200.86 ± 3.45 
F2* 288.54 ± 2.79 251.77 ± 4.52 236.58 ± 3.04 215.73 ± 2.89 
F3 * 286.38 ± 1.84 256.25 ± 3.28 240.23 ±0.59 222.35 ± 2.25 
F4 ns 265.74 ± 3.92 261.03 ± 2.35 260.56 ± 3.29 246.17 ± 4.48 
F5 ns 270.15 ± 3.88 265.72 ± 2.46 260.19 ± 3.08 252.79 ± 2.81 
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2 Pharmacological antidiabetic study of Polyherbal 
formulation of Lawsonia inermis and Azadirachta 
indica:- 
2.1 Alloxan Induced Diabetes
18
: D.Ray et al., 2006. ( Full 
reference of Alloxan) 
Animals:- Albino wistar male rats weighing 150-200g was 
used for the present study. They were maintained in the 
animal house of Gyan Vihar Shool of Pharmacy for 
experimental purpose. The animals were maintained under 
controlled conditions of temperature (23 ± 2C), humidity 
(50 ± 5%) and 12-h light-dark cycles. All the animals were 
acclimatized for seven days before the study. The animals 
were randomized into experimental and control groups and 
housed individually in sanitized polypropylene cages 
containing sterile paddy husk as bedding. They had free 
access to standard pellets as basal diet and water ad 
libitum. Animals were habituated to laboratory conditions 
for 48 hours prior to experimental protocol to minimize if 
any of non-specific stress. All the studies conducted were 
approved by the Institutional Animal Ethical Committee 
(IAEC) of Gyan Vihar School of Pharmacy. According to 
prescribed guidelines of Committee for the Purpose of 
Control and Supervision of Experiments on Animals 
(CPCSEA), Government of India. We selected male 
animals for all our studies, since females are shown to be 
protected from changes in lipid–induced insulin action. 
Induction of Experimental Diabetes:- 
The acclimatized animals were kept fasting for 24 hours 
with water ad libitum and injected intraperitonially a dose 
of 120mg/kg of alloxan mono hydrate in normal saline. 
After one hour, the animals were provided standard 
laboratory diet ad libitum. The blood glucose level was 
checked before alloxanisation and 24 hour after 
alloxanisation by withdrawing blood from the tip of the tail 
of each rat under anaesthesia. The blood glucose level was 
measured as above. Animals were considered diabetic 
when the blood glucose level was raised beyond 225mg/dl. 
This condition was observed at the end of 48 hrs after 
Alloxanisation. 
Experimental Procedure:- 
Forty Two albino rats weighing 150-200g were fasted for 
24hr and were divided into Seven groups of six animals in 
each. The groups included: 
1) Group I   :     as Vehicle received 5% 
gum acacia in normal saline, 1ml/200g rat. 
2) Group II (F1) :     received 1 ml/rat p.o . 
3) Group III (F2) :     received 1 ml/rat p.o . 
4) Group IV (F3) :     received 1 ml/rat p.o . 
5) Group V (F4) :     received 1 ml/rat p.o . 
6) Group VI (F5) :     received 1 ml/rat p.o 
7) Group VII  :    as Standard received 
Glibenclamide (0.5 mg/kg p.o. 10% w/v, 1ml/200 g rat).            
One milliliter of blood from the tail of each rat was 
collected at ‘0’ day. Than at 2nd day, 5th day and 10th day 
subsequently, blood samples were collected again from the 
treated animals and blood glucose was estimated   by 
digital display glucometer.   
Statistical Analysis:- 
Results are expressed as mean ± SD. The differences 
between experimental groups were compared by one-way 
Analysis of Variance (ANOVA) followed by Bonferroni’s 
test. The results were considered statistically significant 
when P<0.05. (Table 1) 
2.2 Streptozotocin Induced Diabetes
18 
Animals:- Albino wistar male rats weighing 150-200g was 
used for the present study. They were maintained in the 
animal house of Gyan Vihar School of Pharmacy for 
experimental purpose. The animals were maintained under 
controlled conditions of temperature (23 ± 2C), humidity 
(50 ± 5%) and 12-h light-dark cycles. All the animals were 
acclimatized for seven days before the study. The animals 
were randomized into experimental and control groups and 
housed individually in sanitized polypropylene cages 
containing sterile paddy husk as bedding. They had free 
access to standard pellets as basal diet and water ad 
libitum. Animals were habituated to laboratory conditions 
for 48 hours prior to experimental protocol to minimize if 
any of non-specific stress. All the studies conducted were 
approved by the Institutional Animal Ethical Committee 
(IAEC) of Gyan Vihar School of Pharmacy. According to 
prescribed guidelines of Committee for the Purpose of 
Control and Supervision of Experiments on Animals 
(CPCSEA), Government of India. We selected male 
animals for all our studies, since females are shown to be 
protected from changes in lipid–induced insulin action.                
Induction of Experimental Diabetes:- 
Healthy Wistar strain albino rats of either sex weighing 
about 150-200 grams were taken. Animals were deprived 
to food for 16 hours but allowed free access to water after 
that blood sample was collected from tail of rats and 
measure blood glucose level by using digital display 
glucometer. Then they were injected with streptozotocin 
dissolved in 0.1M sodium citrate and citric acid at a dose 
of 60 mg/kg body weight intraperitoneally. Then animals 
were kept for 21 days during which food and water was 
allowed. After 7 and 21days of streptozotocin 
administration blood glucose level, body weight, grip 
strength and pain sensation measurements were taken. The 
animals showed fasting blood glucose level above 250 
mg/dl considered diabetic after that they were divided into 
seven groups in which each group contain six animals. 
After that the administered control, standard and test drug 
orally. The blood glucose level, body weight, of each rat 
were taken weekly after oral administration of 
drug/extracts. The mean values of these parameters were 
taken for each group and compared with the value of 
standard drug. 
Estimation of Body Weight:  
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Diabetic animals show reduction in body weight hence 
body weight of all the animals measured every week till 
the completion of study. 
Estimation of Blood Glucose level:  
The blood samples were collected from rat-tail vein on day 
before injecting the streptozotocin and on subsequent 7and 
21 days after injection of streptozotocin for estimation of 
blood glucose level. The blood glucose estimation was 
done weekly after administration of test compounds, with 
the help of glucometer. (Table 2) 
Statistical Analysis:- 
Statistical analysis was carried out as per standard method. 
All results were expressed as mean ± S.D. Groups of data 
were compared with the analysis of variance (ANOVA) 
followed by Dunnett’s t-test values for statistical 
significance P>0.01 was considered significant. (Table 3) 
RESULTS 
Effect of Alloxan on blood glucose level: 
As the Hypoglycemic activity of F1 to F5 was studied both 
in normal and alloxan induced diabetic rats, it was 
observed that F1, F2, F3 found to be significant decrease 
(P<0.01) in blood glucose level, while F4 & F5 were not 
significant (P>0.01).  
Effect of Streptozotocin on body weight and blood 
glucose level: 
The body weight decreased rapidly in STZ treated diabetic 
rats and the blood glucose levels increased rapidly after 
STZ injection. The present study evaluates Diabetes and 
Diabetic Body Weight parameters over a period of 
fourteen days after treatment with Polyherbal formulation 
of Lawsonia inermis and Azadirachta indica. 
 
 
Figure 1: Effet of F1 , F2, F3, F4 & F5 on alloxan induced diabetic rats 
 
 
Figure 2: Effect of F1, F2, F3, F4 and F5 on body weight of SZT-induced diabetic rats 
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Table 2: Polyherbal Formulation of Lawsonia inermis and Azadirachta indica 
S.No. Formulation Lawsonia inermis Azadirachta indica 
1 F1 10gm 0gm 
2 F2 7.5gm 2.5gm 
3 F3 50gm 50gm 
4 F4 2.5gm 7.5gm 
5 F5 0gm 10gm 
 
Table 3: The effect of F1, F2, F3, F4 and F5 on body weight of SZT-induced diabetic rats 
Groups 
Change in body weight on different days 
Day-1 Day-7 Day-21 Day-28 Day-35 
Control 
180.33±7.65 190.33±11.69 201.66±13.66 208.33±10.80 214.16±10.20 
Diabetics 
control 179.5±5.54 158.83±5.84
*** 140.00±7.74*** 134.50±7.84*** 127.16±7.08*** 
Glimiperide 
drug(1 mg/kg) 178.16±7.27 155.83±7.35*** 138.83±10.30*** 147.00±7.74*** 159.50±7.58***,a 
F1  
   180.83±8.61 164.5±3.93*** 141.66±11.69*** 147.66±10.83*** 156.66±10.87***,a 
F2 
179.16±9.70 157.5±5.00*** 142.16±5.11*** 151.33±4.54*** 160.16±6.96***,a 
F3 
178.83±3.76 163.33±8.75*** 139.66±9.93*** 148.00±9.69*** 158.16±9.08***,a 
F4 
183.5±6.89 159.16±6.64*** 137.16±9.28*** 147.83±9.06*** 157.33±6.86***,a 
F5 
176.5±3.65 165±2.69*** 139.25±6.26*** 150.56±5.23*** 155.32±8.96***,a 
Values are mean ± SD, n=6, where *** is P<0.001 when compared to control group, and a= P<0.001 when compared to diabetic control group. 
 
Table 4: The effect of F1, F2, F3, F4 and F5 on Blood glucose level of SZT-induced diabetic rats 
Groups Change in blood glucose levels on different days 
Day-1 Day-7 Day-21 Day-28 Day-35 
 Control 
83.33±5.50 80.16±4.35 82±6.13 82.16±3.18 83.83±7.98 
Diabetic 
control 82.66±5.20 303.33±10.69
*** 312±6.32*** 319.16±5.98*** 325.5±6.56*** 
Glimiperide 
drug(1 mg/kg) 82.5±7.36 308±8.22
*** 316.66±8.38*** 81.83±5.34b,a*** 82±5.47b,a*** 
F1  
82±5.96 308±13.74*** 318.33±7.22*** 133.66±17.96***,a*** 129.16±8.08***,a*** 
F2 
82±5.01 302.33±11.91*** 313.5±6.65*** 123.66±11.69***,a**** 115.33±9.62***,a*** 
F3 
83.33±6.18 305.83±13.79*** 318.16±9.19*** 121±9.20***,a*** 101.66±6.97**,a*** 
F4 
81.83±4.11 310.33±12.11*** 319.66±10.96*** 108.5±10.69***,a*** 90±7.01b,a*** 
F5 
86.72±3.25 299.25±8.56*** 309.66±8.56*** 152.5±6.23*** 103.25±6.23,a* 
Values are mean ± SD, n=6, ** = P<0.01, *** = P<0.001 when compared to  control group, b= ns when compared to  control group,  a***= P<0.001 
when compared to diabetic control group, c= ns when compared to standard group. 
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Figure 3: The effect of F1, F2, F3, F4 and F5 on Blood glucose level of SZT-induced diabetic rats 
 
Measurements of body weight of the rats of all 
experimental groups are shown in table 2 and figure 2. The 
body weight increased normally in control rats, while STZ 
induced diabetic rats (Diabetic control) showed a 
significant decrease in body weight as soon as one week 
post-STZ injection (Pre: 179.5 ± 5.54 to 158.83 ± 5.84, 
P<0.01). A progressive loss of body weight was noted after 
21 days (pre: 179.5 ± 5.54 to 140± 7.74, P<0.001). The 
maximum decrease in body weight was observed after 5 
weeks STZ-injection (pre: 179.5 ± 5.54 to 127.16 ± 7.08, 
P<0.001). The weight of the animals of other groups was 
also decreased significantly till day 21 as compared to 
control group (Table 2). On the day 21 the animals treated 
with Glimiperide drug (1 mg/kg), F1, F2, F3, F4 and F5 
were observed with significant increase in their body 
weight as compared to Diabetic control group of animals. 
The blood glucose level of all experimental groups, except  
control group was increased significantly after the STZ 
injection till day 21 (Table 3 and Figure 3). In the diabetic 
group (Diabetic control) the blood glucose levels increased 
to the maximum measurable value of 325.5 ± 6.56 mg/dl 
on day 35 and found to be significant increased (P<0.001) 
compared to the value of day1 was 82.66 ± 5.20 mg/dl. In 
contrast, control animals remained normoglycaemic during 
the entire testing period of 14 days (Table 3). The animals 
treated with glimiperide drug (1 mg/kg), F1, F2, F3, F4 
and F5 were observed with significant decrease (P<0.001) 
in blood glucose level compared to Diabetic control group. 
CONCLUSION 
The results obtained from the present study show that the 
Polyherbal Formulation of Lawsonia inermis and 
Azadirachta indica had beneficial effect on blood glucose 
level in alloxan & streptozocin induced diabetic rats and 
also on body weight in streptozocin induced diabetic rats.  
Lawsonia inermis and Azadirachta indica appears to be 
useful material for further studies, leading to possible drug 
development for diabetes as their combined formulation on 
different concentration gradient had shown the potential 
role of antidiabetic activity. Further Phytochemical 
investigations are required to elucidate the exact 
mechanism of action & also the active principles 
responsible for such effects. 
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